News
Southwest Hospitals MRI Center's Commitment to State-of-the-Art Technology at the Heart of Nearly 20-Year Relationship with MedInformatix RIS
July 28, 2010 9:35 am | by Bio-Medicine.Org | CommentsLOS ANGELES , July 28 /- Since its formation in 1987, Oak Lawn, Ill. -based Southwest Hospitals MRI Center has leveraged cutting edge imaging and other technology to provide the community just southwest of Chicago with among the area's highest quality MRI studies. Each of its technicians...
Encision's Technology Recognized as A Means to Eliminate Surgery Burns
July 28, 2010 9:35 am | by Bio-Medicine.Org | CommentsBOULDER, Colo. , July 28 /- Encision Inc. (OTC Bulletin Board: ECIA), a medical device company owning patented surgical technology that is emerging as a standard of care in minimally-invasive surgery, recognized as a technology to eliminate visceral burns during monopolar electrical...
Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
July 28, 2010 9:35 am | by Bio-Medicine.Org | CommentsNATICK, Massachusetts , July 28, 2010 /- - Company Expands Market-leading Family of Neurovascular Stents Boston Scientific Corporation (NYSE: BSX ) today announced the U.S. and European launches of the Neuroform EZ(TM) Stent System, its fourth-generation intracranial aneurysm stent syste...
Teva Respiratory Announces Positive Results From Phase III Trial of BDP HFA Nasal Aerosol in Seasonal Allergic Rhinitis
July 28, 2010 9:34 am | by Bio-Medicine.Org | CommentsHORSHAM, Pa. , July 28 /- Teva Respiratory today announced positive results from a Phase III trial evaluating the efficacy and safety of beclomethasone dipropionate (BDP) hydrofluoroalkane (HFA) Nasal Aerosol in the treatment of seasonal allergic rhinitis (SAR). The study met all efficacy...
Siemens Showcases Broad Array of Innovative Diagnostic Solutions at 2010 AACC and ASCLS Annual Meetings and Clinical Lab Expo
July 28, 2010 9:32 am | by Bio-Medicine.Org | CommentsANAHEIM, Calif. , July 28 /- Siemens Healthcare Diagnostics is showcasing a broad array of new products, services and solutions for clinicians at the American Association for Clinical Chemistry's 2010 Clinical Lab Expo in Anaheim, California from July 27 through July 29, 2010 (Booth...
IBM and UPMC Partner to Make 'Smart' Patient Room Even Smarter
July 28, 2010 8:33 am | by IBM | CommentsPITTSBURGH, July 28 /PRNewswire-FirstCall/ -- IBM (NYSE: IBM) and UPMC (University of Pittsburgh Medical Center) are teaming up to bring "smarter" hospital rooms to patients nationwide. Created by UPMC three years ago to bring the right patient information to the bedside when it's needed,...
FDA fast-tracks EMD Serono MS drug
July 28, 2010 7:33 am | by Mass High Tech: The Journal of New England Technology | CommentsEMD Serono, which is developing an oral tablet for the treatment of Multiple Sclerosis, has received a priority review by the U.S. Food and Drug Administration.
Nanoblasts Move Molecules, Proteins and DNA into Living Cells
July 28, 2010 7:32 am | by Georgia Tech Institute of Technology | CommentsUsing chemical "nanoblasts" that punch tiny holes in the protective membranes of cells, researchers have demonstrated a new technique for getting therapeutic small molecules, proteins and DNA directly into living cells.
Federal Register: Neurological and Physical Medicine Devices; Designation of Special Controls for Certain Class II Devices and Exemption From Premarket Notification; Reopening...
July 28, 2010 6:34 am | by U.S. Food & Drug Administration | CommentsThe FDA is reopening until 9/7/2010, the comment period for the proposed rule published in the Federal Register of April 5, 2010 (75 FR 17093). The document proposed to amend certain neurological and physical medicine device regulations to establish...
Federal Register: Radiological Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting
July 28, 2010 6:33 am | by U.S. Food & Drug Administration | CommentsOn 9/24/2010, the committee will discuss, make recommendations, and vote on a premarket approval application for the Selenia C Digital Breast Tomosynthesis System, sponsored by Hologic, Inc. The Selenia C Digital Breast Tomosynthesis System is intended...
Bionovo, Inc. to Announce Second Quarter Fiscal Year 2010 Financial Results on Wednesday, August 4, 2010
July 28, 2010 6:33 am | by Bio-Medicine.Org | CommentsEMERYVILLE, Calif. , July 28 /- Bionovo, Inc. (Nasdaq: BNVI ) announced today that it will release financial results for the second quarter of fiscal year 2010 ended June 30, 2010 on Wednesday, August 4, 2010 . The Company will conduct a conference call and webcast to review the financial...
Warner Chilcott Announces Earnings Release Date and Conference Call for Second Quarter 2010 Financial Results
July 28, 2010 6:33 am | by Bio-Medicine.Org | CommentsARDEE, Ireland , July 28 /- Warner Chilcott plc (Nasdaq: WCRX) today announced that it will issue its second quarter 2010 financial results prior to the market opening on Friday, August 6, 2010 . In addition to issuing a press release, the Company will host a conference call for all...
Curemark Opens Autism Trials at New Jersey Site
July 28, 2010 6:33 am | by Bio-Medicine.Org | CommentsRYE, N.Y. , July 28 /- Curemark, LLC ( www.curemark.com ), a drug research and development company focused on the treatment of neurological diseases, announced that Saint Peter's University Hospital in New Brunswick, New Jersey , is participating in the company's Phase III clinical trials...
Dyax numbers get boost from fees, drug sales
July 28, 2010 5:42 am | by Mass High Tech: The Journal of New England Technology | CommentsCambridge-based biotech firm Dyax Corp. saw a surge in revenue for the second quarter, climbing to $15.1 million from $4.8 million for the same quarter in 2009. The bulk of that increase, $13.2 million, came from development and license fees.
Topaz Pharmaceuticals Announces Positive Data from Topical Ivermectin Trials Presented at Society of Pediatric Dermatology
July 28, 2010 5:39 am | by Bio-Medicine.Org | CommentsHORSHAM, Pa. , July 28 /- Topaz Pharmaceuticals Inc., a privately held biotechnology company, announced positive results of studies of topical ivermectin cream, which it is developing as a potential treatment of Pediculus humanus capitis (head lice). In a Phase 2 dose-ranging...
